BJS Academy SoMe review March 2024

🥇BJS Award: call for nominations opening soon!
➡️ https://t.co/UClt1NdAvA

The BJS Award:
💫 Celebrates excellence in surgical science.
💫 Recognises a discovery, innovation or scientific study that has changed clinical practice.

Nominate an exceptional individual for the BJS… pic.twitter.com/1goFvIVkKI

— BJS Academy (@BJSAcademy) March 21, 2024

📢 It's that time of year again!

🤝 We are now recruiting the next intake of Editor Assistants to join the editorial teams of BJS and @BjsOpen

📆 Deadline for applications is 30th April 2024

🙌 Reposts would be greatly appreciated!

😷 Find out about more about this exciting… pic.twitter.com/DXAsWRUvCv

— BJS (@BJSurgery) March 12, 2024

The empty pelvis syndrome: a core data set from the @PelvExGroup collaborative
➡️ https://t.co/GXKecJD9W2

Empty pelvis syndrome (EPS) is a significant source of morbidity following #pelvicexenteration, but is undefined.
The aim of this study is to facilitate the design of future… pic.twitter.com/6NgYwU5gME

— BJS (@BJSurgery) March 10, 2024

🎇 Real-world practice and outcomes in pilonidal surgery: Pilonidal Sinus Treatment Studying The Options (PITSTOP) cohort

😷The aim of this study was to provide real-world data on current surgical practice and report patient and risk-adjusted outcomes, informing future trial… pic.twitter.com/8hWOAkljeq

— BJS (@BJSurgery) March 15, 2024

Prehabilitation: tertiary prevention matters
➡️ https://t.co/S87JRk0RrD#prehabilitation is unquestionably positioned to achieve the Quadruple Aim:
1⃣ Enhancing the quality of care through tertiary prevention
2⃣ Curbing costs
3⃣ Incorporating and improving patients’ experience… pic.twitter.com/2XiTs7ruQi

— BJS (@BJSurgery) March 4, 2024

Active surveillance for clinical complete responders after chemoradiotherapy for #oesophageal squamous cell #carcinoma
➡️ https://t.co/V6dVcsKjeP

Active surveillance is a safe and feasible option for the treatment of oesophageal squamous cell carcinoma. Overall survival was… pic.twitter.com/oRs77AZRTM

— BJS (@BJSurgery) March 3, 2024

Daily handover in surgery: systematic review and a novel taxonomy of interventions and outcomes
➡️https://t.co/16oAS7wWjh

This systematic review aimed to summarize the interventions available to improve end-of-shift surgical handover. A novel taxonomy of interventions and… pic.twitter.com/jhsBvKRRb5

— BJS Open (@BjsOpen) March 2, 2024

🚨 Invaluable @asgbi guidelines to support decision-making for the general surgeon in pregnancy 🚨 Comprehensive review of investigations + treatment for common surgical emergencies. Watch author video + bookmark this paper 🔖 you will need it one day https://t.co/U9j77LgqG5… pic.twitter.com/Bwyi316PtY

— BJS (@BJSurgery) March 13, 2024

Impact of type 2 diabetes on complications after primary #breastcancer surgery: Danish population-based cohort study
➡️ https://t.co/ehjHLOU9FR

Prevalent type 2 diabetes affects the risk of surgical complications after primary breast cancer surgery, particularly among women who… pic.twitter.com/QwNepgBHph

— BJS (@BJSurgery) March 30, 2024

Palliative surgery: state of the science and future directions
➡️ https://t.co/xsKaBI37dW

Palliative surgical procedures are operations that aim to alleviate symptoms in a patient with serious, life-limiting illness.
They are common, particularly within the field of… pic.twitter.com/t20aoNuBwG

— BJS (@BJSurgery) March 23, 2024

Webinar: Winner of the BJS Award 2023, Professor Henrik Kehlet
➡️ https://t.co/t23upH89tg

Join us for a special webinar featuring Professor Henrik Kehlet, recipient of the BJS Award 2023. 🏆 Discover his groundbreaking surgical achievements in hernia surgery, pain relief, and… pic.twitter.com/KF39See5Dx

— BJS Academy (@BJSAcademy) March 23, 2024

Point-of-care tests (POCT) for haemoglobin are increasingly used to guide intraoperative transfusion, however, their accuracy compared to central laboratory tests is unknown.

What do you estimate is the mean differences between POCT and central laboratory haemoglobin values?…

— BJS Open (@BjsOpen) March 10, 2024

#systematicreview of targeted axillary dissection in node-positive #breastcancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement
➡️ https://t.co/y5qDNJM4jK

In node-positive (cN+) breast cancer treated with neoadjuvant systemic… pic.twitter.com/lOZhUOQ7a3

— BJS (@BJSurgery) March 29, 2024

Well done, Sameh and colleagues! 👏

🤖 Robotic and laparoscopic colectomy: propensity score-matched outcomes from a national cancer database

➡️Read the article here:https://t.co/9i1xch5Vqv https://t.co/DIq5XCvhc7

— BJS (@BJSurgery) March 15, 2024

⁉️#polltime ⁉️
In osteoporotic vertebral compression fractures 👴🧓, is percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP) superior in terms of cement leakage (most common complication)❓💉🪨💉🪨#SoMe4Surgery #MedTwitter #SurgEd #Surgery @for_surgery…

— BJS Open (@BjsOpen) March 3, 2024

Protocolized care pathways in #Emergency general surgery: a #systematicreview and #metaanalysis
➡️ https://t.co/pO3yGRRXsc

The delivery of postoperative care following #emgensurg is highly variable and significantly impacts postoperative outcomes.
Protocolized postoperative… pic.twitter.com/kuAzufhYqu

— BJS (@BJSurgery) March 24, 2024

Early experience with #robotic #pancreatoduodenectomy versus open pancreatoduodenectomy: nationwide propensity-score-matched analysis
➡️ https://t.co/yqadUFXAgV

🏥18 centres
🧍698 robotic pancreatoduodenectomy vs 698 propensity-score-matched patients open pancreatoduodenectomy… pic.twitter.com/FwNtsw2WTU

— BJS (@BJSurgery) March 16, 2024

⚡️Kicking off our CTLI miniseries⚡️
🆕Chronic limb-threatening ischaemia: current knowledge and future perspectives
➡️ https://t.co/m68VDsl4iG

"The incidence of peripheral arterial disease (PAD) has risen dramatically, and it is estimated to affect around 200 million people… pic.twitter.com/hYyFmqdQZw

— BJS Academy (@BJSAcademy) March 27, 2024

Surgical stress response in 🤖 robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): #RCT
➡️ https://t.co/Q2UN7URJaJ

The aim of this #RCT was to investigate the perioperatively induced systemic stress response and clinical and #PROMs for patients undergoing… pic.twitter.com/PCOsu7gOeq

— BJS (@BJSurgery) March 6, 2024

📽️Author video: 'Intra-tumoural bromelain and N-acetylcysteine (BromAc®) for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial'

Results demonstrate efficacy and safety of intratumoural BromAc® as a therapeutic option in the palliative setting for patients with… pic.twitter.com/NilSShRmtZ

— BJS (@BJSurgery) March 17, 2024